Focusing on Digital Health, Medtech & Devices

The main programme for the 11th Annual HTIF will feature more than 7 hours of high-level speeches and panel discussions. In addition, there will be a global company showcase of 25+ presentations by established public, private, emerging and seed companies, offering innovative solutions and seeking investment and partnering opportunities. This will include a limited number of live presentations taking place in dedicated parallel presenting tracks, alongside virtual company showcases, which will be available on-demand during the virtual week. The organisers anticipate 250+ delegates from Digital Health, MedTech/Device companies, banks, investors and advisors with part of the audience participating virtually.

The conference is free to attend for Investors.

Qualified investors include:
Funds managers, private equity, venture investors and accredited investors who actively invest in biotech, life science, digital medicine and medical technology companies. Angel investors, family offices and non-profit organizations with funds invested in healthcare or life sciences may also qualify for a complimentary registration. Buy-side and sell-side research analysts should have active coverage of the healthcare and life sciences sector.

There are only two free passes available per company.